News
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Cuvposa
Generic name
glycopyrrolate
Manufacturer
MEDEXUS Pharmaceuticals, Inc.
Indication(s)
chronic severe drooling, neurologic (pediatric)
Project Number
SR0613-000
Call for patient input
2019-04-11
Patient input deadline
2019-06-03
Submit patient input
Submit...
CADTH is pleased to announce the appointment of Dr. Nicole Mittmann, MSc., PhD, as CADTH Chief Scientist and Vice-President of Evidence Standards.
Dr. Mittmann will lead CADTH’s shared science groups, including our Health Economics, Research Information Services, and Scientific Affairs teams. She will also be responsible for building networks wi...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Aimovig
Generic name
erenumab
Manufacturer
Novartis Pharmaceuticals Canada Inc.
Indication(s)
Migraine
Project Number
SR0578-000
Call for patient input
2019-04-04
Patient input deadline
2019-05-27
Submit patient input
Submit
Register as Clinical Expert
Register...
CADTH has received the following notice(s) of pending drug submission(s).
Brand name
Lokelma
Generic name
sodium zirconium cyclosilicate
Manufacturer
AstraZeneca Canada Inc.
Indication(s)
Hyperkalemia, adults
Project Number
SR0612-000
Call for patient input
2019-04-04
Patient input deadline
2019-05-27
Submit patient input
Submit
Register as Cli...
